LOW-DOSE STREPTOZOTOCIN-INDUCED DIABETES IN MICE .1. COURSE OF CANDIDA-ALBICANS INFECTION

被引:16
|
作者
MOSCI, P
VECCHIARELLI, A
CENCI, E
PULITI, M
BISTONI, F
机构
[1] Department of Experimental Medicine and Biochemical Sciences, Microbiology Section, University of Perugia, 06100 Perugia, Via del Giochetto
关键词
D O I
10.1006/cimm.1993.1175
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Diabetic patients are highly susceptible to microbial and fungal infections. To better understand the immune mechanisms underlying the diabetic host-parasite relationship, we studied the course of systemic infection with Candida albicans in mice with low-dose streptozotocin-induced diabetes. For this purpose, we used a low-pathogenic strain of C. albicans, PCA-2, which causes a chronic infection in the intact host. Injection of PCA-2 cells into diabetic mice caused a lethal acute infection. The levels of interferon-γ (IFN-γ,) determined in sera and splenocyte culture supernatants from diabetic mice were significantly higher than those in control mice. Moreover, splenic macrophages from diabetic mice were functionally activated relative to normal macrophages, as evaluated by significantly augmented C. albicans killing in vitro. However, when diabetic mice were infected with PCA-2, IFN-γ levels dropped dramatically to undetectable levels during the first week of infection and there was a marked decrease in macrophage activation. These data suggest that the levels of IFN-γ production early in infection might have a crucial role in generating the susceptibility of diabetic mice to infection. © 1993 Academic Press. All rights reserved.
引用
收藏
页码:27 / 35
页数:9
相关论文
共 50 条
  • [31] ANALYSIS OF 22 IMMUNOMODULATORY SUBSTANCES FOR EFFICACY IN LOW-DOSE STREPTOZOTOCIN-INDUCED DIABETES
    KOLB, H
    OSCHILEWSKI, M
    OSCHILEWSKI, U
    SCHWAB, E
    MOUME, CM
    GREULICH, B
    BURKART, V
    ZIELASEK, J
    KIESEL, U
    DIABETES RESEARCH CLINICAL AND EXPERIMENTAL, 1987, 6 (01): : 21 - 27
  • [32] PROTECTION FROM MULTIPLE LOW-DOSE STREPTOZOTOCIN-INDUCED DIABETES BY AN INTERFERON INDUCER
    NAJI, A
    MARKMANN, J
    BLANK, K
    GADZIK, J
    BARKER, CF
    SURGICAL FORUM, 1982, 33 : 221 - 224
  • [33] PREVENTION OF LOW-DOSE STREPTOZOTOCIN-INDUCED DIABETES BY ACETYL-HOMOCYSTEINE-THIOLACTONE
    PAPACCIO, G
    DIABETES RESEARCH AND CLINICAL PRACTICE, 1991, 13 (1-2) : 95 - 102
  • [34] PROBUCOL ATTENUATED HYPERGLYCEMIA IN MULTIPLE LOW-DOSE STREPTOZOTOCIN-INDUCED DIABETIC MICE
    SHIMIZU, H
    UEHARA, Y
    SHIMOMURA, Y
    TANAKA, Y
    KOBAYASHI, I
    LIFE SCIENCES, 1991, 49 (18) : 1331 - 1338
  • [35] CYCLOSPORIN ENHANCES DIABETES INDUCED BY LOW-DOSE STREPTOZOTOCIN TREATMENT IN MICE
    SESTIER, C
    ODENTPOGU, S
    BONNEVILLE, M
    MAUREL, C
    LANG, F
    SAI, P
    IMMUNOLOGY LETTERS, 1985, 10 (01) : 57 - 60
  • [36] Methadone ameliorates multiple-low-dose streptozotocin-induced type 1 diabetes in mice
    Amirshahrokhi, K.
    Dehpour, A. R.
    Hadjati, J.
    Sotoudeh, M.
    Ghazi-Khansari, M.
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2008, 232 (01) : 119 - 124
  • [37] Early manifestations in multiple-low-dose streptozotocin-induced diabetes in mice
    Karabatas, LM
    Pastorale, C
    de Bruno, LF
    Maschi, F
    Pivetta, OH
    Lombardo, YB
    Chemes, H
    Basabe, JC
    PANCREAS, 2005, 30 (04) : 318 - 324
  • [38] NFκB1 (p50)-deficient mice are not susceptible to multiple low-dose streptozotocin-induced diabetes
    Mabley, JG
    Haskó, G
    Liaudet, L
    Soriano, F
    Southan, GJ
    Salzman, AL
    Szabó, C
    JOURNAL OF ENDOCRINOLOGY, 2002, 173 (03) : 457 - 464
  • [39] ESSENTIAL FATTY-ACID DEFICIENCY PREVENTS MULTIPLE LOW-DOSE STREPTOZOTOCIN-INDUCED DIABETES IN CD-1 MICE
    WRIGHT, JR
    LEFKOWITH, JB
    SCHREINER, G
    LACY, PE
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (16) : 6137 - 6141
  • [40] NO-mediated cytotoxicity contributes to multiple low-dose streptozotocin-induced diabetes but not to NOD diabetes
    Yasuda, Hisafumi
    Jin, Zhenzi
    Nakayama, Maki
    Yamada, Katsumi
    Kishi, Minoru
    Okumachi, Yasuyo
    Arai, Takashi
    Moriyama, Hiroaki
    Yokono, Koichi
    Nagata, Masao
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2009, 83 (02) : 200 - 207